HK1135923A1 - Pharmaceutical agent having long-lasting effect of treating arthritic disorders - Google Patents

Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Info

Publication number
HK1135923A1
HK1135923A1 HK10102737.2A HK10102737A HK1135923A1 HK 1135923 A1 HK1135923 A1 HK 1135923A1 HK 10102737 A HK10102737 A HK 10102737A HK 1135923 A1 HK1135923 A1 HK 1135923A1
Authority
HK
Hong Kong
Prior art keywords
cross
arthritic disorders
long
hyaluronic acid
pharmaceutical agent
Prior art date
Application number
HK10102737.2A
Other languages
English (en)
Inventor
Kenji Miyamoto
Keiji Yoshioka
Katsuya Takahashi
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Publication of HK1135923A1 publication Critical patent/HK1135923A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/738—Cross-linked polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK10102737.2A 2006-12-06 2010-03-16 Pharmaceutical agent having long-lasting effect of treating arthritic disorders HK1135923A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86879806P 2006-12-06 2006-12-06
PCT/JP2007/073987 WO2008069348A1 (en) 2006-12-06 2007-12-06 Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Publications (1)

Publication Number Publication Date
HK1135923A1 true HK1135923A1 (en) 2010-06-18

Family

ID=39203191

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10102737.2A HK1135923A1 (en) 2006-12-06 2010-03-16 Pharmaceutical agent having long-lasting effect of treating arthritic disorders
HK13113014.0A HK1185556A1 (en) 2006-12-06 2013-11-21 Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK13113014.0A HK1185556A1 (en) 2006-12-06 2013-11-21 Pharmaceutical agent having long-lasting effect of treating arthritic disorders

Country Status (10)

Country Link
US (3) US8889652B2 (ja)
EP (3) EP2094280A1 (ja)
JP (3) JP5291621B2 (ja)
KR (1) KR101460815B1 (ja)
CN (2) CN101573123B (ja)
AU (1) AU2007328871B2 (ja)
CA (1) CA2672002C (ja)
HK (2) HK1135923A1 (ja)
TW (2) TWI419697B (ja)
WO (1) WO2008069348A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889652B2 (en) 2006-12-06 2014-11-18 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
ITTO20110428A1 (it) * 2011-05-13 2012-11-14 Rottapharm Spa Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
US9301971B2 (en) 2013-03-08 2016-04-05 Novartis Ag Peptides and compositions for treatment of joint damage
KR20160029818A (ko) * 2013-07-08 2016-03-15 덴카 주식회사 코어 쉘형 가교 히알루론산 겔 입자, 그의 제조 방법 및 의료용 재료
US20150133561A1 (en) * 2013-11-12 2015-05-14 Vizuri Health Sciences Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
WO2016002983A1 (ko) * 2014-06-30 2016-01-07 (주)메디톡스 가교된 히알루론난을 유효성분으로 포함하는 골관절염 치료용 약제학적 조성물 및 그를 이용한 골관절염 치료 방법
KR102357341B1 (ko) * 2014-11-06 2022-02-03 주식회사 엘지생활건강 숙지황 추출물을 포함하는 히알루론산 생성 촉진용 조성물과 이의 이용
KR101521411B1 (ko) * 2015-02-05 2015-05-19 박재우 뼈 및 연골을 포함한 관절질환 치료용 조성물 및 이의 제조방법
KR101637883B1 (ko) * 2015-09-30 2016-07-21 선바이오(주) 폴리에틸렌글리콜 수화젤 주사제
KR101895950B1 (ko) * 2015-12-18 2018-09-06 (주)한국비엠아이 골관절염 치료를 위한 친수화된 설파살라진 및 히알루론산을 포함하는 조성물 및 이의제조방법
EP3597199A4 (en) 2017-03-14 2021-01-20 Seikagaku Corporation COMPOSITION FOR THE TREATMENT OF JOINT DISEASES, AND KIT CONTAINING THIS COMPOSITION
AR116566A1 (es) 2018-10-03 2021-05-19 Novartis Ag Administración sostenida de polipéptidos similares a la angiopoyetina 3
CN115444840B (zh) * 2022-09-15 2023-08-25 四川大学 一种前药、两性离子水凝胶及其制备方法、应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61210034A (ja) 1985-03-15 1986-09-18 Seikagaku Kogyo Co Ltd 関節症治療剤
US5356883A (en) * 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
JPH0574571A (ja) 1990-12-25 1993-03-26 Ricoh Co Ltd 電界発光素子
JP2855307B2 (ja) 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
JP3343181B2 (ja) * 1995-09-20 2002-11-11 生化学工業株式会社 桂皮酸誘導体
US6025444A (en) * 1994-11-17 2000-02-15 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Cinnamic acid derivative
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
JP3955107B2 (ja) * 1995-05-01 2007-08-08 生化学工業株式会社 架橋多糖の製造法
WO1997018244A1 (en) * 1995-11-15 1997-05-22 Seikagaku Corporation Photocured cross-linked-hyaluronic acid gel and method of preparation thereof
DE69822285T2 (de) * 1998-02-27 2005-01-27 Stichting Hyppomedics Verfahren zur Herstellung von vernetzter Hyaluronsäure
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
CA2399039C (en) * 2000-02-03 2009-09-22 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, method of its production and medical material containing it
JP4172176B2 (ja) * 2000-12-19 2008-10-29 生化学工業株式会社 光反応性ヒアルロン酸およびその製造方法ならびに光架橋ヒアルロン酸および医用材料
EP1217008B1 (en) * 2000-12-19 2006-03-01 Seikagaku Corporation Photocurable hyaluronic acid derivative and process for producing the same, and photocured crosslinked hyaluronic acid derivative and medical material using the same
JP4990446B2 (ja) 2001-05-28 2012-08-01 電気化学工業株式会社 関節症治療用注入剤
JP4958368B2 (ja) 2002-02-28 2012-06-20 電気化学工業株式会社 架橋ヒアルロン酸
KR101288748B1 (ko) 2004-09-15 2013-07-23 세이가가쿠 고교 가부시키가이샤 광반응성 다당, 광가교 다당 생성물, 이들의 제조 방법 및이로부터 제조된 의료용 재료
SI2664334T1 (sl) * 2004-12-30 2015-06-30 Genzyme Corporation Reĺ˝imi za intraartikularno viskosuplemantacijo
CA2614312C (en) * 2005-07-06 2014-02-18 Seikagaku Corporation Drug-introduced photo-crosslinked hyaluronic acid derived gel
KR20130109259A (ko) 2005-10-12 2013-10-07 세이가가쿠 고교 가부시키가이샤 점막에 적용하는 작용제 및 그것의 제조 방법
US8889652B2 (en) 2006-12-06 2014-11-18 Seikagaku Corporation Pharmaceutical agent having long-lasting effect of treating arthritic disorders
JO3008B1 (ar) * 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم

Also Published As

Publication number Publication date
CN101573123A (zh) 2009-11-04
JP2010511596A (ja) 2010-04-15
EP2910248A1 (en) 2015-08-26
WO2008069348A9 (en) 2009-08-20
TW200831113A (en) 2008-08-01
AU2007328871B2 (en) 2013-11-21
JP2014237704A (ja) 2014-12-18
EP2094280A1 (en) 2009-09-02
US8889652B2 (en) 2014-11-18
US20150094280A1 (en) 2015-04-02
KR20090087496A (ko) 2009-08-17
TWI528964B (zh) 2016-04-11
TWI419697B (zh) 2013-12-21
AU2007328871A1 (en) 2008-06-12
CN103356694A (zh) 2013-10-23
JP5889976B2 (ja) 2016-03-22
US20110053885A1 (en) 2011-03-03
CA2672002A1 (en) 2008-06-12
CN103356694B (zh) 2015-09-02
US20150283169A1 (en) 2015-10-08
JP5600192B2 (ja) 2014-10-01
JP5291621B2 (ja) 2013-09-18
TW201414479A (zh) 2014-04-16
WO2008069348A1 (en) 2008-06-12
JP2013209417A (ja) 2013-10-10
CA2672002C (en) 2015-06-02
US9301972B2 (en) 2016-04-05
KR101460815B1 (ko) 2014-11-12
HK1185556A1 (en) 2014-02-21
US9616087B2 (en) 2017-04-11
CN101573123B (zh) 2013-06-05
EP2386306A1 (en) 2011-11-16

Similar Documents

Publication Publication Date Title
HK1135923A1 (en) Pharmaceutical agent having long-lasting effect of treating arthritic disorders
BRPI0514297A (pt) composições farmacêuticas para liberação controlada de compostos biologicamente ativos
WO2007133637A3 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
FR2911138B1 (fr) Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
BR112012012815A8 (pt) composto derivado de 1,3-difenil-prop-2-en-1-ona, uso do referido composto, e composto, e, composição farmacêutica
ATE554778T1 (de) Verfahren, pharmazeutische zusammensetzungen und hergestellte artikel zur verabreichung von therapeutischen zellen an das zentrale nervensystem eines tiers
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
CR10458A (es) Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias
WO2008097924A3 (en) Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
BR0111126A (pt) Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
HRP20161197T1 (hr) 24-norudca za liječenje autoimunog hepatitisa
WO2005115432A3 (en) Treatment of ocular diseases and disorders using lantibiotic compositions
WO2007028022A3 (en) Novel compounds as p2x7 modulators and uses thereof
WO2007100758A3 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
FR2919869B1 (fr) Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
WO2007056142A3 (en) Methods of preventing the serotonin syndrome and compositions for use therefor
TW200634021A (en) 3,6-bicyclolides
EP2215054B8 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2006065721A3 (en) 11, 12-lactone bicyclolides
WO2006099410A3 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20221202